4/A
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-19-053184
CEO, Pres, CFO, Treas & Secy sold 1,350 shares at $1.70 ($2,295)
From the SEC's structured data for this filing
Trades in this filing
KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-18 | Sale : show line 1 in the form | −1,350 | $1.70 | $2,295 | 8,926 | D |
| Open-market sales · 1,350 sh · avg $1.70 · $2,295 | ||||||
Loading xslF345X03/doc4a.xml…